{
  "DOI": "10.1186/1479-7364-4-4-238",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/1479-7364-4-4-238",
  "alternative-id": [
    "246"
  ],
  "article-number": "238",
  "author": [
    {
      "affiliation": [],
      "family": "Marques",
      "given": "Sara Correia",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Ikediobi",
      "given": "Ogechi N",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2019,
        12,
        11
      ]
    ],
    "date-time": "2019-12-11T02:28:29Z",
    "timestamp": 1576031309000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        2,
        11
      ]
    ],
    "date-time": "2021-02-11T13:31:08Z",
    "timestamp": 1613050268000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        18
      ]
    ],
    "date-time": "2024-04-18T20:35:19Z",
    "timestamp": 1713472519420
  },
  "is-referenced-by-count": 48,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2010,
        4,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2010,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2010,
            4,
            1
          ]
        ],
        "date-time": "2010-04-01T00:00:00Z",
        "timestamp": 1270080000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/1479-7364-4-4-238.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/1479-7364-4-4-238/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/1479-7364-4-4-238.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2010,
        4,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2010,
        4,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2010,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.2217/14622416.9.6.703",
      "author": "CP Strassburg",
      "doi-asserted-by": "publisher",
      "first-page": "703",
      "journal-title": "Pharmacogenomics",
      "key": "246_CR1",
      "unstructured": "Strassburg CP: Pharmacogenetics of Gilbert's syndrome. Pharmacogenomics. 2008, 9: 703-715. 10.2217/14622416.9.6.703.",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1592/phco.28.6.755",
      "author": "MA Perera",
      "doi-asserted-by": "publisher",
      "first-page": "755",
      "journal-title": "Pharmacotherapy",
      "key": "246_CR2",
      "unstructured": "Perera MA, Innocenti F, Ratain MJ: Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: Are we there yet?. Pharmacotherapy. 2008, 28: 755-768. 10.1592/phco.28.6.755.",
      "volume": "28",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.pharmthera.2004.10.013",
      "author": "TK Kiang",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "journal-title": "Pharmacol Ther",
      "key": "246_CR3",
      "unstructured": "Kiang TK, Ensom MH, Chang TK: UDP-glucuronosyl-transferases and clinical drug-drug interactions. Pharmacol Ther. 2005, 106: 97-132. 10.1016/j.pharmthera.2004.10.013.",
      "volume": "106",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.jhep.2008.12.030",
      "author": "TO Lankisch",
      "doi-asserted-by": "publisher",
      "first-page": "1010",
      "journal-title": "J Hepatol",
      "key": "246_CR4",
      "unstructured": "Lankisch TO, Behrens G, Ehmer U, Möbius U, et al: Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy -- An extended haplotype of genetic variants increases risk in indinavir treatment. J Hepatol. 2009, 50: 1010-1018. 10.1016/j.jhep.2008.12.030.",
      "volume": "50",
      "year": "2009"
    },
    {
      "DOI": "10.1124/dmd.107.017806",
      "author": "D Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "2270",
      "journal-title": "Drug Metab Dispos",
      "key": "246_CR5",
      "unstructured": "Zhang D, Zhang D, Cui D, Gambardella J, et al: Characterization of the UDP glucuronosyltransferase activity of human liver microsomes genotyped for the UGT1A1*28 polymorphism. Drug Metab Dispos. 2007, 35: 2270-2280. 10.1124/dmd.107.017806.",
      "volume": "35",
      "year": "2007"
    },
    {
      "author": "F Innocenti",
      "first-page": "596",
      "journal-title": "Drug Metab Dispos",
      "key": "246_CR6",
      "unstructured": "Innocenti F, Iyer L, Ratain MJ: Pharmacogenetics of anticancer agents: Lessons from amonafide and irinotecan. Drug Metab Dispos. 2001, 29: 596-600.",
      "volume": "29",
      "year": "2001"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-03-3295",
      "author": "Y Duguay",
      "doi-asserted-by": "publisher",
      "first-page": "1202",
      "journal-title": "Cancer Res",
      "key": "246_CR7",
      "unstructured": "Duguay Y, McGrath M, Lépine J, Gagné JF, et al: The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk. Cancer Res. 2004, 64: 1202-1207. 10.1158/0008-5472.CAN-03-3295.",
      "volume": "64",
      "year": "2004"
    },
    {
      "author": "C Guillemette",
      "first-page": "950",
      "journal-title": "Cancer Res",
      "key": "246_CR8",
      "unstructured": "Guillemette C, Millikan RC, Newman B, Housman DE, et al: Genetic polymorphisms in uridine diphospho-glucuronosyltrans-ferase 1A1 and association with breast cancer among African Americans. Cancer Res. 2000, 60: 950-956.",
      "volume": "60",
      "year": "2000"
    },
    {
      "DOI": "10.1186/bcr818",
      "author": "R Sparks",
      "doi-asserted-by": "publisher",
      "first-page": "R488",
      "journal-title": "Breast Cancer Res",
      "key": "246_CR9",
      "unstructured": "Sparks R, Ulrich CM, Bigler J, Tworoger SS, et al: UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res. 2004, 6: R488-R498. 10.1186/bcr818.",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1006/bbrc.2002.6400",
      "author": "K Jemnitz",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "246_CR10",
      "unstructured": "Jemnitz K, Lengyel G, Vereczkey L: In vitro induction of bilirubin conjugation in primary rat hepatocyte culture. Biochem Biophys Res Commun. 2002, 291: 29-33. 10.1006/bbrc.2002.6400.",
      "volume": "291",
      "year": "2002"
    },
    {
      "DOI": "10.1128/AAC.01468-08",
      "author": "LA Wenning",
      "doi-asserted-by": "publisher",
      "first-page": "2852",
      "journal-title": "Antimicrob Agents Chemother",
      "key": "246_CR11",
      "unstructured": "Wenning LA, Hanley WD, Brainard DM, Petry AS, et al: Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravir. Antimicrob Agents Chemother. 2009, 53: 2852-2856. 10.1128/AAC.01468-08.",
      "volume": "53",
      "year": "2009"
    },
    {
      "DOI": "10.1016/0065-2571(95)00006-2",
      "author": "CH Brierley",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "journal-title": "Adv Enzyme Regul",
      "key": "246_CR12",
      "unstructured": "Brierley CH, Senafi SB, Clarke D, Hsu MH, et al: Regulation of the human bilirubin UDP-glucuronosyltransferase gene. Adv Enzyme Regul. 1996, 36: 85-97.",
      "volume": "36",
      "year": "1996"
    },
    {
      "DOI": "10.1097/01.fpc.0000182784.77630.48",
      "author": "J Ramírez",
      "doi-asserted-by": "publisher",
      "first-page": "79",
      "journal-title": "Pharmacogenet Genomics",
      "key": "246_CR13",
      "unstructured": "Ramírez J, Komoroski BJ, Mirkov S, Graber AY, et al: Study of the genetic determinants of UGT1A1 inducibility by phenobarbital in cultured human hepatocytes. Pharmacogenet Genomics. 2006, 16: 79-86. 10.1097/01.fpc.0000182784.77630.48.",
      "volume": "16",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2004.07.173",
      "author": "F Innocenti",
      "doi-asserted-by": "publisher",
      "first-page": "1382",
      "journal-title": "J Clin Oncol",
      "key": "246_CR14",
      "unstructured": "Innocenti F, Undevia SD, Iyer L, Chen PX, et al: Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol. 2004, 22: 1382-1388. 10.1200/JCO.2004.07.173.",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1093/jnci/djm115",
      "author": "JM Hoskins",
      "doi-asserted-by": "publisher",
      "first-page": "1290",
      "journal-title": "J Natl Cancer Inst",
      "key": "246_CR15",
      "unstructured": "Hoskins JM, Goldberg RM, Qu P, Ibrahim JG, et al: UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. J Natl Cancer Inst. 2007, 99: 1290-1295. 10.1093/jnci/djm115.",
      "volume": "99",
      "year": "2007"
    },
    {
      "DOI": "10.1200/JCO.2008.19.0314",
      "author": "E Cecchin",
      "doi-asserted-by": "publisher",
      "first-page": "2457",
      "journal-title": "J Clin Oncol",
      "key": "246_CR16",
      "unstructured": "Cecchin E, Innocenti F, D'Andrea M, Corona G, et al: Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan. J Clin Oncol. 2009, 27: 2457-2465. 10.1200/JCO.2008.19.0314.",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.clpt.6100330",
      "author": "G Corona",
      "doi-asserted-by": "publisher",
      "first-page": "601",
      "journal-title": "Clin Pharm Ther",
      "key": "246_CR17",
      "unstructured": "Corona G, Vaccher E, Sandron S, et al: Lopinavirritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma. Clin Pharm Ther. 2008, 83: 601-606. 10.1038/sj.clpt.6100330.",
      "volume": "83",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1365-2125.2009.03363.x",
      "author": "J Trontelj",
      "doi-asserted-by": "publisher",
      "first-page": "437",
      "journal-title": "Br J Clin Pharmacol",
      "key": "246_CR18",
      "unstructured": "Trontelj J, Marc J, Zavratnik A, Bogataj M, et al: Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol. 2009, 67: 437-444. 10.1111/j.1365-2125.2009.03363.x.",
      "volume": "67",
      "year": "2009"
    },
    {
      "DOI": "10.1038/clpt.2009.12",
      "author": "LA Wenning",
      "doi-asserted-by": "publisher",
      "first-page": "623",
      "journal-title": "Clin Pharmacol Ther",
      "key": "246_CR19",
      "unstructured": "Wenning LA, Petry AS, Kost JT, Jin B, et al: Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphisms. Clin Pharmacol Ther. 2009, 85: 623-627. 10.1038/clpt.2009.12.",
      "volume": "85",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S0213-005X(08)76569-8",
      "author": "MM Placeres Alsina",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "Enferm Infecc Microbiol Clin",
      "key": "246_CR20",
      "unstructured": "Placeres Alsina MM, Tuset Creus M, Miró JM: Pharmacokinetics and interactions of raltegravir. Enferm Infecc Microbiol Clin. 2008, 26: 23-28.",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1086/466531",
      "author": "M Rotger",
      "doi-asserted-by": "publisher",
      "first-page": "1381",
      "journal-title": "J Infect Dis",
      "key": "246_CR21",
      "unstructured": "Rotger M, Taffé P, Bleiber G, Gunthard HF, et al: Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. J Infect Dis. 2005, 192: 1381-1386. 10.1086/466531.",
      "volume": "192",
      "year": "2005"
    },
    {
      "DOI": "10.1002/hep.21361",
      "author": "TO Lankisch",
      "doi-asserted-by": "publisher",
      "first-page": "1324",
      "journal-title": "Hepatology",
      "key": "246_CR22",
      "unstructured": "Lankisch TO, Moebius U, Wehmeier M, Behrens G, et al: Gilbert's disease and atazanavir: From phenotype to UDP-glucuronosyl-transferase haplotype. Hepatology. 2006, 44: 1324-1332. 10.1002/hep.21361.",
      "volume": "44",
      "year": "2006"
    },
    {
      "DOI": "10.1093/jac/dkp317",
      "author": "PL Anderson",
      "doi-asserted-by": "publisher",
      "first-page": "1071",
      "journal-title": "J Antimicrob Chemother",
      "key": "246_CR23",
      "unstructured": "Anderson PL, Aquilante CL, Gardner EM, Predhomme J, et al: Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors. J Antimicrob Chemother. 2009, 64: 1071-1079. 10.1093/jac/dkp317.",
      "volume": "64",
      "year": "2009"
    },
    {
      "DOI": "10.1097/01.qai.0000225013.53568.69",
      "author": "PL Anderson",
      "doi-asserted-by": "publisher",
      "first-page": "441",
      "journal-title": "J Acquir Immune Defic Syndr",
      "key": "246_CR24",
      "unstructured": "Anderson PL, Lamba J, Aquilante CL, Schuetz E, et al: Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: A pilot study. J Acquir Immune Defic Syndr. 2006, 42: 441-449. 10.1097/01.qai.0000225013.53568.69.",
      "volume": "42",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s00280-009-1096-4",
      "author": "J Meza-Junco",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Cancer Chemother Pharmacol",
      "key": "246_CR25",
      "unstructured": "Meza-Junco J, Chu QS, Christensen O, Rajagopalan P, et al: UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib. Cancer Chemother Pharmacol. 2009, 65: 1-4. 10.1007/s00280-009-1096-4.",
      "volume": "65",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ejca.2006.08.032",
      "author": "K Mross",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "Eur J Cancer",
      "key": "246_CR26",
      "unstructured": "Mross K, Steinbild S, Baas F, Gmehling D, et al: Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib. Eur J Cancer. 2007, 43: 55-63. 10.1016/j.ejca.2006.08.032.",
      "volume": "43",
      "year": "2007"
    },
    {
      "DOI": "10.1124/dmd.106.012732",
      "author": "Z Wen",
      "doi-asserted-by": "publisher",
      "first-page": "371",
      "journal-title": "Drug Metab Dispos",
      "key": "246_CR27",
      "unstructured": "Wen Z, Tallman MN, Ali SY, Smith PC: UDP-glucuro-nosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: Structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics. Drug Metab Dispos. 2007, 35: 371-380.",
      "volume": "35",
      "year": "2007"
    },
    {
      "DOI": "10.1093/clinchem/45.6.897",
      "author": "ML Biondi",
      "doi-asserted-by": "crossref",
      "first-page": "897",
      "journal-title": "Clin Chem",
      "key": "246_CR28",
      "unstructured": "Biondi ML, Turri O, Dilillo D, Stival G, et al: Contribution of the TATA-box genotype (Gilbert syndrome) to serum bilirubin concentrations in the Italian population. Clin Chem. 1999, 45: 897-898.",
      "volume": "45",
      "year": "1999"
    },
    {
      "DOI": "10.1053/jhep.2001.0103303le03",
      "author": "RH Te Morsche",
      "doi-asserted-by": "publisher",
      "first-page": "765",
      "journal-title": "Hepatology",
      "key": "246_CR29",
      "unstructured": "Te Morsche RH, Zusterzeel PL, Raijmakers MT, Roes EM, et al: Polymorphism in the promoter region of the bilirubin UDP-glucuronosyltransferase (Gilbert's syndrome) in healthy Dutch subjects. Hepatology. 2001, 33: 765-10.1053/jhep.2001.0103303le03.",
      "volume": "33",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0025-7753(00)71617-4",
      "author": "JM Fernández Salazar",
      "doi-asserted-by": "publisher",
      "first-page": "540",
      "journal-title": "Med Clin(Barc)",
      "key": "246_CR30",
      "unstructured": "Fernández Salazar JM, Remacha Sevilla A, del Río Conde E, Baiget Bastús M: Distribution of the A(TA)7TAA genotype associated with Gilbert syndrome in the Spanish population. Med Clin(Barc). 2000, 115: 540-541.",
      "volume": "115",
      "year": "2000"
    },
    {
      "DOI": "10.1046/j.1440-1746.1999.01984.x",
      "author": "B Burchell",
      "doi-asserted-by": "publisher",
      "first-page": "960",
      "journal-title": "J Gastroenterol Hepatol",
      "key": "246_CR31",
      "unstructured": "Burchell B, Hume R: Molecular genetic basis of Gilbert's syndrome. J Gastroenterol Hepatol. 1999, 14: 960-966. 10.1046/j.1440-1746.1999.01984.x.",
      "volume": "14",
      "year": "1999"
    },
    {
      "DOI": "10.1002/ajmg.10209",
      "author": "KY Fertrin",
      "doi-asserted-by": "publisher",
      "first-page": "117",
      "journal-title": "Am J Med Genet",
      "key": "246_CR32",
      "unstructured": "Fertrin KY, Gonc¸alves MA, Saad ST, Costa FF: Frequencies of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil. Am J Med Genet. 2002, 118: 117-119.",
      "volume": "118",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S1079-9796(03)00071-8",
      "author": "A Premawardhena",
      "doi-asserted-by": "publisher",
      "first-page": "98",
      "journal-title": "Blood Cells Mol Dis",
      "key": "246_CR33",
      "unstructured": "Premawardhena A, Fisher CA, Liu YT, Verma IC, et al: The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): Hematologic and evolutionary implications. Blood Cells Mol Dis. 2003, 31: 98-101. 10.1016/S1079-9796(03)00071-8.",
      "volume": "31",
      "year": "2003"
    },
    {
      "DOI": "10.1111/j.1349-7006.2007.00541.x",
      "author": "SR Jada",
      "doi-asserted-by": "publisher",
      "first-page": "1461",
      "journal-title": "Cancer Sci",
      "key": "246_CR34",
      "unstructured": "Jada SR, Lim R, Wong CI, Shu X, et al: Pole of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C \u003e A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci. 2007, 98: 1461-1467. 10.1111/j.1349-7006.2007.00541.x.",
      "volume": "98",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.tpj.6500424",
      "author": "A Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "journal-title": "Pharmacogenomics J",
      "key": "246_CR35",
      "unstructured": "Zhang A, Xing Q, Qin S, Du J, et al: Intra-ethnic differences in genetic variants of the UGT-glucuronosyltransferase 1A1 gene in Chinese populations. Pharmacogenomics J. 2007, 7: 333-338. 10.1038/sj.tpj.6500424.",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.1097/01.fpc.0000197465.14340.d4",
      "author": "MA Boyd",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "journal-title": "Pharmacogenet Genomics",
      "key": "246_CR36",
      "unstructured": "Boyd MA, Srasuebkul P, Ruxrungtham K, Mackenzie PI, et al: Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir. Pharmacogenet Genomics. 2006, 16: 321-329. 10.1097/01.fpc.0000197465.14340.d4.",
      "volume": "16",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1440-1746.2004.03370.x",
      "author": "K Takeuchi",
      "doi-asserted-by": "publisher",
      "first-page": "1023",
      "journal-title": "J Gastroenterol Hepatol",
      "key": "246_CR37",
      "unstructured": "Takeuchi K, Kobayashi Y, Tamaki S, et al: Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects. J Gastroenterol Hepatol. 2004, 19: 1023-1028. 10.1111/j.1440-1746.2004.03370.x.",
      "volume": "19",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.bjc.6604721",
      "author": "I Sekine",
      "doi-asserted-by": "publisher",
      "first-page": "1757",
      "journal-title": "Br J Cancer",
      "key": "246_CR38",
      "unstructured": "Sekine I, Yamamoto N, Nishio K, Saijo N: Emerging ethnic differences in lung cancer therapy. Br J Cancer. 2008, 99: 1757-1762. 10.1038/sj.bjc.6604721.",
      "volume": "99",
      "year": "2008"
    },
    {
      "DOI": "10.1073/pnas.95.14.8170",
      "author": "E Beutler",
      "doi-asserted-by": "publisher",
      "first-page": "8170",
      "journal-title": "Proc Natl Acad SciUSA",
      "key": "246_CR39",
      "unstructured": "Beutler E, Gelbart T, Demina A: Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism?. Proc Natl Acad SciUSA. 1998, 95: 8170-8174. 10.1073/pnas.95.14.8170.",
      "volume": "95",
      "year": "1998"
    },
    {
      "DOI": "10.1038/jp.2008.214",
      "author": "D Brites",
      "doi-asserted-by": "publisher",
      "first-page": "S8",
      "issue": "Suppl 1",
      "journal-title": "J Perinatol",
      "key": "246_CR40",
      "unstructured": "Brites D, Fernandes A, Falcão AS, Gordo AC, et al: Biological risks for neurological abnormalities associated with hyperbilirubinemia. J Perinatol. 2009, 29 (Suppl 1): S8-13.",
      "volume": "29",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2006.09.6115",
      "author": "JM van der Bol",
      "doi-asserted-by": "publisher",
      "first-page": "2719",
      "journal-title": "J Clin Oncol",
      "key": "246_CR41",
      "unstructured": "van der Bol JM, Mathijssen RH, Loos WJ, Friberg LE, et al: Cigarette smoking and irinotecan treatment: Pharmacokinetic interaction and effects on neutropenia. J Clin Oncol. 2007, 25: 2719-2726. 10.1200/JCO.2006.09.6115.",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1093/jn/135.5.1051",
      "author": "S Peterson",
      "doi-asserted-by": "crossref",
      "first-page": "1051",
      "journal-title": "J Nutr",
      "key": "246_CR42",
      "unstructured": "Peterson S, Bigler J, Horner NK, Potter JD, et al: Cruciferae interact with the UGT1A1*28 polymorphism to determine serum bilirubin levels in humans. J Nutr. 2005, 135: 1051-1055.",
      "volume": "135",
      "year": "2005"
    },
    {
      "DOI": "10.3109/03602530903209288",
      "author": "MH Court",
      "doi-asserted-by": "publisher",
      "first-page": "202",
      "journal-title": "Drug Metab Rev",
      "key": "246_CR43",
      "unstructured": "Court MH: Interindividual variability in hepatic drug glucuronidation: Studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev. 2010, 42: 202-217.",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.3945/jn.108.097279",
      "author": "MR Saracino",
      "doi-asserted-by": "publisher",
      "first-page": "555",
      "journal-title": "J Nutr",
      "key": "246_CR44",
      "unstructured": "Saracino MR, Bigler J, Schwarz Y, Chang JL, et al: Citrus fruit intake is associated with lower serum bilirubin concentration among women with the UGT1A1*28 polymorphism. J Nutr. 2009, 139: 555-560. 10.3945/jn.108.097279.",
      "volume": "139",
      "year": "2009"
    },
    {
      "DOI": "10.1093/jn/137.4.890",
      "author": "JL Chang",
      "doi-asserted-by": "crossref",
      "first-page": "890",
      "journal-title": "J Nutr",
      "key": "246_CR45",
      "unstructured": "Chang JL, Bigler J, Schwarz Y, Li SS, et al: UGT1A1 polymorphism is associated with serum bilirubin concentrations in a randomized, controlled, fruit and vegetable feeding trial. J Nutr. 2007, 137: 890-897.",
      "volume": "137",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ijcard.2006.04.003",
      "author": "TO Cheng",
      "doi-asserted-by": "publisher",
      "first-page": "236",
      "journal-title": "Int J Cardiol",
      "key": "246_CR46",
      "unstructured": "Cheng TO: Green tea may inhibit warfarin. Int J Cardiol. 2007, 115: 236-10.1016/j.ijcard.2006.04.003.",
      "volume": "115",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ijcard.2006.12.002",
      "author": "TO Cheng",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "journal-title": "Int J Cardiol",
      "key": "246_CR47",
      "unstructured": "Cheng TO: Not only green tea but also green leafy vegetables inhibit warfarin. Int J Cardiol. 2008, 125: 101-10.1016/j.ijcard.2006.12.002.",
      "volume": "125",
      "year": "2008"
    },
    {
      "DOI": "10.1038/clpt.2009.30",
      "author": "ON Ikediobi",
      "doi-asserted-by": "publisher",
      "first-page": "28",
      "journal-title": "Clin Pharmacol Ther",
      "key": "246_CR48",
      "unstructured": "Ikediobi ON, Shin J, Nussbaum RL, Phillips KA, et al: Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther. 2009, 86: 28-31. 10.1038/clpt.2009.30.",
      "volume": "86",
      "year": "2009"
    },
    {
      "DOI": "10.1002/cncr.24428",
      "author": "HT Gold",
      "doi-asserted-by": "publisher",
      "first-page": "3858",
      "journal-title": "Cancer",
      "key": "246_CR49",
      "unstructured": "Gold HT, Hall MJ, Blinder V, Schackman BR: Cost-effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer. Cancer. 2009, 115: 3858-3867. 10.1002/cncr.24428.",
      "volume": "115",
      "year": "2009"
    },
    {
      "DOI": "10.2217/14622416.9.5.539",
      "author": "M Obradovic",
      "doi-asserted-by": "publisher",
      "first-page": "539",
      "journal-title": "Pharmacogenomics",
      "key": "246_CR50",
      "unstructured": "Obradovic M, Mrhar A, Kos M: Cost-effectiveness of UGT1A1 genotyping in second line, high-dose, once every 3 weeks irinotecan monotherapy treatment of colorectal cancer. Pharmacogenomics. 2008, 9: 539-549. 10.2217/14622416.9.5.539.",
      "volume": "9",
      "year": "2008"
    }
  ],
  "reference-count": 50,
  "references-count": 50,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/1479-7364-4-4-238"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "The clinical application of UGT1A1pharmacogenetic testing: Gene-environment interactions"
  ],
  "type": "journal-article",
  "volume": "4"
}